Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C

Abstract Background Limited data exist about effective regimens for pharmacological thromboprophylaxis in children with acute coronavirus disease 2019 (COVID‐19) and multisystem inflammatory syndrome in children (MIS‐C). Objectives Study the outcomes of institutional thromboprophylaxis protocol for...

Full description

Bibliographic Details
Main Authors: Anna H. Schmitz, Kelly E. Wood, Elliot L. Burghardt, Bryan P. Koestner, Linder H. Wendt, Aditya V. Badheka, Anjali A. Sharathkumar
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
anticoagulants
child
COVID‐19
heparin
low molecular weight
MIS‐C
Online Access:https://doi.org/10.1002/rth2.12780

Internet

https://doi.org/10.1002/rth2.12780

Similar Items